Glaxosmithkline Share News (GSK)
GSK Share
GSK Share
GSK Share
GSK Share
GSK
GSK Share
GSK Level 2
GSK Live
GSK Broker
GSK Directors
GSK Financial
GSK
GSK Short
GSK
Last checked at -
Wed, 23rd Oct 2013 12:28
(Alliance News) - GSK PLC on Tuesday said it will begin phase 3 trials of a low carbon version of its metered dose inhaler Ventolin using a "next generation" propellant in 2024.
Read more(Alliance News) - European equities jumped in the wake of a cooler-than-expected US inflation reading, which took some sting out of a recent hawkish reassessment of the Federal Reserve interest rate outlook.
Read more(Alliance News) - GSK PLC on Monday announced that a European Medicines Agency panel has given a positive opinion recommending momelotinib to treat myelofibrosis patients with anaemia.
Read more| Friday 10 November | |
| Bodycote PLC | dividend payment date |
| Breedon Group PLC | dividend payment date |
| Chesnara PLC | dividend payment date |
| Finsbury Growth & Income Trust PLC | dividend payment date |
| Invesco Bond Income Plus Ltd | dividend payment date |
| JPMorgan Emerging Markets Investment Trust PLC | dividend payment date |
| Kerry Group PLC | dividend payment date |
| Merchants Trust PLC | dividend payment date |
| Mid Wynd International Investment Trust PLC | dividend payment date |
| Mid Wynd International Investment Trust PLC | special dividend payment date |
| Montanaro UK Smaller Cos Investment Trust PLC | dividend payment date |
| Senior PLC | dividend payment date |
| Spectris PLC | dividend payment date |
| Spirax-Sarco Engineering PLC | dividend payment date |
| Travis Perkins PLC | dividend payment date |
| Monday 13 November | |
| no events scheduled | |
| Tuesday 14 November | |
| no events scheduled | |
| Wednesday 15 November | |
| Coats Group PLC | dividend payment date |
| Ferguson PLC | dividend payment date |
| JP Morgan Mid Cap Investment Trust PLC | dividend payment date |
| Strategic Equity Capital PLC | dividend payment date |
| Thursday 16 November | |
| abrdn Property Income Trust Ltd | ex-dividend payment date |
| Asian Energy Impact Trust PLC | ex-dividend payment date |
| Baillie Gifford Japan Trust PLC | ex-dividend payment date |
| BlackRock Greater Europe Investment Trust PLC | ex-dividend payment date |
| Bunzl PLC | ex-dividend payment date |
| Bytes Technology Group PLC | ex-dividend payment date |
| Centrica PLC | dividend payment date |
| Coca-Cola Europacific Partners PLC | ex-dividend payment date |
| DX Group PLC | ex-dividend payment date |
| Empiric Student Property PLC | ex-dividend payment date |
| Fonix Mobile PLC | ex-dividend payment date |
| GCP Asset Backed Income Fund Ltd | ex-dividend payment date |
| GSK PLC | ex-dividend payment date |
| Hargreaves Lansdown PLC | ex-dividend payment date |
| Henderson Opportunities Trust PLC | ex-dividend payment date |
| ICG Enterprise Trust PLC | ex-dividend payment date |
| James Halstead PLC | ex-dividend payment date |
| Lancashire Holdings Ltd | special ex-dividend payment date |
| Majedie Investments PLC | ex-dividend payment date |
| Marks & Spencer Group PLC | ex-dividend payment date |
| Murray Income Trust PLC | ex-dividend payment date |
| New Star Investment Trust PLC | ex-dividend payment date |
| NextEnergy Solar Fund Ltd | ex-dividend payment date |
| Octopus Renewables Infrastructure Trust PLC | ex-dividend payment date |
| Pershing Square Holdings Ltd | ex-dividend payment date |
| Personal Group Holdings PLC | dividend payment date |
| Redrow PLC | dividend payment date |
| Regional REIT Ltd | ex-dividend payment date |
| Schroder Oriental Income Fund Ltd | ex-dividend payment date |
| Scottish American Investment Co PLC | ex-dividend payment date |
| SCS Group PLC | ex-dividend payment date |
| Shell PLC | ex-dividend payment date |
| Supermarket Income REIT PLC | dividend payment date |
| UK Commercial Property REIT Ltd | ex-dividend payment date |
| Unilever PLC | ex-dividend payment date |
| Wincanton PLC | ex-dividend payment date |
| Copyright 2023 Alliance News Ltd. All Rights Reserved. | |
(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:
Read more(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:
Read more(Alliance News) - Stocks in London took their lead from a positive start on Wall Street to close higher as investors prepare for interest rate decisions in the UK and US.
Read more(Sharecast News) - London's stock market finished in positive territory on Wednesday, with investors keeping a keen eye on the upcoming policy announcement from the US Federal Reserve.
Read more(Alliance News) - GSK PLC on Wednesday hailed the performance of the world's first approved respiratory syncytial virus vaccine Arexvy, as it reported a rise in profit and revenue.
Read more(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of key central bank decisions, as investors were cheered by some strong updates from large-cap listings.
Read more(Alliance News) - Stocks in London are called higher on Wednesday, with the main focal point for the day being the upcoming US interest rate decision.
Read more(Sharecast News) - GSK announced a robust third quarter on Wednesday, prompting an upgrade to its full-year guidance.
Read moreGSK PLC - Brentford, west London-based pharmaceutical maker - Jemperli, whose generic name is dostarlimab, meets endpoint of overall survival in phase III Ruby trial on adult patients with primary advanced or recurrent endometrial cancer. Jemperli, combined with standard-of-care chemotherapy, followed by dostarlimab, demonstrated a "statistically significant and clinically meaningful benefit" to the patients in the trial.
Read more(Sharecast News) - GSK reported encouraging outcomes from part one of the 'RUBY' phase three trial evaluating the efficacy of 'Jemperli', or dostarlimab, with standard chemotherapy for treating adult patients with advanced or recurrent endometrial cancer on Monday.
Read more(Alliance News) - GSK PLC on Thursday said its subsidiary ViiV Healthcare has received marketing authorisation in China for its cabotegravir treatment, marketed as Vocabria.
Read more
Last checked at